Search: David Kalergis
June 17, 2017
A small Charlottesville biopharmaceutical company recently was granted entry to the Nasdaq stock exchange. Diffusion Pharmaceuticals (DFFN) has attracted millions of dollars in private investment to develop cancer drugs from a unique molecule invented at the University of Virginia. The company went public in 2016 to fund its first Phase ...